VeraniJRMcGeeLSchragSJ; Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of perinatal group B streptococcal disease—revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010;59(RR-10):1-36.
2.
FalcigliaGHagemanJRSchreiberMAlexanderK. Antibiotic therapy and early onset sepsis. Neoreviews. 2012;13(2):e86-e91.
3.
Cohen-WolkowiezMMoranCBenjaminDK. Early and late onset sepsis in late preterm infants. Pediatr Infect Dis J. 2009;28:1052-1056.
4.
StollBJHansenNFanaroffAA. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med. 2002;347:240-247.
5.
SchuchatA. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin Microbiol Rev. 1998;11:497-513.
6.
LinFYBrennerRAJohnsonYR. The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease. Am J Obstet Gynecol. 2001;184:1204-1210.
7.
SiegelJDShannonKMDePasseBM. Recurrent infection associated with penicillin-tolerant group B streptococci: a report of two cases. J Pediatr. 1981;99:920-924.
8.
SchragSJZywickiSFarleyMM. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med. 2000;342:15-20.
9.
SchragSJZellERLynfieldR. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med. 2002;347:233-239.
10.
StollBJHansenNISanchezPJ. Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics. 2011;127:817-826.
